Clinical Trial: Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors

Brief Summary: The role of postoperative concurrent chemotherapy (CCT) has not been established for salivary gland tumors (SGTs). This prospective study was conducted to evaluate the feasibility and safety of customized CCT regimens based on the gene targets of SGTs.

Detailed Summary:
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Current Primary Outcome: Acute toxicity profiles, graded according to the NCI CTCAE version 3.0 [ Time Frame: up to 6 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Disease-free survival [ Time Frame: 2 years ]

from date of enrollment until date of first documented disease progression or death from any cause, assessed up to 2 years


Original Secondary Outcome: Same as current

Information By: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Dates:
Date Received: September 30, 2016
Date Started: September 2013
Date Completion: February 2017
Last Updated: September 30, 2016
Last Verified: September 2016